LeIF A
LeIF A Brand names, LeIF A Analogs
LeIF A Brand Names Mixture
- No information avaliable
LeIF A Chemical_Formula
C860H1353N227O255S9
LeIF A RX_link
No information avaliable
LeIF A fda sheet
LeIF A msds (material safety sheet)
LeIF A Synthesis Reference
No information avaliable
LeIF A Molecular Weight
19241.1
LeIF A Melting Point
No information avaliable
LeIF A H2O Solubility
No information avaliable
LeIF A State
Liquid
LeIF A LogP
-0.336
LeIF A Dosage Forms
No information avaliable
LeIF A Indication
For the treatment of oral warts arising from HIV infection
LeIF A Pharmacology
Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase) and protein kinase R.
LeIF A Absorption
No information avaliable
LeIF A side effects and Toxicity
No information avaliable
LeIF A Patient Information
No information avaliable
LeIF A Organisms Affected
Humans and other mammals
